Compass Capital Corp’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$856K Buy
3,283
+26
+0.8% +$6.06K 0.28% 83
2026
Q1
$721K Buy
3,257
+20
+0.6% +$4.66K 0.26% 87
2025
Q4
$773K Sell
3,237
-17
-0.5% -$3.36K 0.3% 82
2025
Q3
$620K Buy
3,254
+1,503
+86% +$258K 0.27% 84
2025
Q2
$304K Sell
1,751
-3
-0.2% -$461 0.14% 138
2025
Q1
$274K Sell
1,754
-1,879
-52% -$294K 0.14% 145
2024
Q4
$529K Buy
+3,633
New +$563K 0.21% 107

Other funds holding JNJ

Compass Capital Corp's JNJ Position: Q2 2026 in Review

Compass Capital Corp increased its Johnson & Johnson (JNJ) stake by 0.8% in Q2 2026, buying an estimated $6.06K and bringing the position to 3,283 shares worth $856K. The position accounts for 0.28% of the portfolio, ranked #83.

Compass Capital Corp first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Compass Capital Corp held 3,283 shares of Johnson & Johnson worth $856K as of Q2 2026.
  • Compass Capital Corp bought 26 Johnson & Johnson shares in Q2 2026, an estimated $6.06K.
  • Johnson & Johnson made up 0.28% of Compass Capital Corp's portfolio in Q2 2026, its #83 holding.
  • Compass Capital Corp first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Compass Capital Corp's 13F filing for Q2 2026, filed 13 Aug 2026.